These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37309679)

  • 1. Risk of Tuberculosis Disease in People With Chronic Kidney Disease Without Kidney Failure: A Systematic Review and Meta-analysis.
    Luczynski P; Holmes T; Romanowski K; Arbiv OA; Cook VJ; Clark EG; Johnston JC
    Clin Infect Dis; 2023 Oct; 77(8):1194-1200. PubMed ID: 37309679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis.
    Al-Efraij K; Mota L; Lunny C; Schachter M; Cook V; Johnston J
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1493-9. PubMed ID: 26614191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between chronic kidney disease and tuberculosis; a comparative cohort study in England.
    Ruzangi J; Iwagami M; Smeeth L; Mangtani P; Nitsch D
    BMC Nephrol; 2020 Oct; 21(1):420. PubMed ID: 32998703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis incidence in patients with chronic kidney disease: a systematic review and meta-analysis.
    Alemu A; Bitew ZW; Diriba G; Seid G; Eshetu K; Chekol MT; Berhe N; Gumi B
    Int J Infect Dis; 2022 Sep; 122():188-201. PubMed ID: 35609860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Approaches to Stop Hypertension and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies.
    Mozaffari H; Ajabshir S; Alizadeh S
    Clin Nutr; 2020 Jul; 39(7):2035-2044. PubMed ID: 31669002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of chronic kidney disease in tuberculosis: a population-based cohort study.
    Shen TC; Huang KY; Chao CH; Wang YC; Muo CH; Wei CC; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC; Kao CH
    QJM; 2015 May; 108(5):397-403. PubMed ID: 25352683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study.
    Cho PJ; Wu CY; Johnston J; Wu MY; Shu CC; Lin HH
    Int J Tuberc Lung Dis; 2019 May; 23(5):555-562. PubMed ID: 31097063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants for adults with chronic kidney disease.
    Colombijn JM; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RW
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD008176. PubMed ID: 37916745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis.
    Chung EYM; Palmer SC; Natale P; Krishnan A; Cooper TE; Saglimbene VM; Ruospo M; Au E; Jayanti S; Liang A; Jie Deng DJ; Chui J; Higgins GY; Tong A; Wong G; Teixeira-Pinto A; Hodson EM; Craig JC; Strippoli GFM
    Am J Kidney Dis; 2021 Dec; 78(6):804-815. PubMed ID: 34364906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis and risk of cancer: A systematic review and meta-analysis.
    Luczynski P; Poulin P; Romanowski K; Johnston JC
    PLoS One; 2022; 17(12):e0278661. PubMed ID: 36584036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for heart failure in people with chronic kidney disease.
    Lunney M; Ruospo M; Natale P; Quinn RR; Ronksley PE; Konstantinidis I; Palmer SC; Tonelli M; Strippoli GF; Ravani P
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012466. PubMed ID: 32103487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease correlates with increased risk of pulmonary tuberculosis before initiating renal replacement therapy: A cohort study in Taiwan.
    Cheng KC; Liao KF; Lin CL; Liu CS; Lai SW
    Medicine (Baltimore); 2018 Sep; 97(39):e12550. PubMed ID: 30278552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.
    Campbell JR; Johnston JC; Ronald LA; Sadatsafavi M; Balshaw RF; Cook VJ; Levin A; Marra F
    Am J Kidney Dis; 2019 Jan; 73(1):39-50. PubMed ID: 30269868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary interventions for adults with chronic kidney disease.
    Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet agents for chronic kidney disease.
    Natale P; Palmer SC; Saglimbene VM; Ruospo M; Razavian M; Craig JC; Jardine MJ; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD008834. PubMed ID: 35224730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of low bone mineral density (T-score ≤  - 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis.
    Duarte MP; Ribeiro HS; Neri SGR; Almeida LS; Oliveira JS; Viana JL; Lima RM
    Osteoporos Int; 2023 Mar; 34(3):467-477. PubMed ID: 36370217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.